In the latest quarter, 7 analysts provided ratings for Texas Roadhouse TXRH, showcasing a mix of bullish and bearish perspectives.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 1 | 3 | 3 | 0 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 0 | 3 | 1 | 0 | 0 |
| 3M Ago | 1 | 0 | 1 | 0 | 0 |
The 12-month price targets, analyzed by analysts, offer insights with an average target of $119.14, a high estimate of $130.00, and a low estimate of $110.00. Observing a 2.49% increase, the current average has risen from the previous average price target of $116.25.
Interpreting Analyst Ratings: A Closer Look
An in-depth analysis of recent analyst actions unveils how financial experts perceive Texas Roadhouse. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| John Ivankoe | JP Morgan | Announces | Neutral | $120.00 | - |
| Nick Setyan | Wedbush | Raises | Outperform | $130.00 | $120.00 |
| Nick Setyan | Wedbush | Maintains | Outperform | $120.00 | - |
| Nick Setyan | Wedbush | Raises | Outperform | $120.00 | $110.00 |
| Brian Mullan | Piper Sandler | Announces | Neutral | $110.00 | - |
| Jake Bartlett | Truist Securities | Lowers | Buy | $124.00 | $129.00 |
| Brian Harbour | Morgan Stanley | Raises | Equal-Weight | $110.00 | $106.00 |
Key Insights:
- Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Texas Roadhouse. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Texas Roadhouse compared to the broader market.
- Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Texas Roadhouse's stock. This comparison reveals trends in analysts' expectations over time.
Capture valuable insights into Texas Roadhouse's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
Stay up to date on Texas Roadhouse analyst ratings.
Delving into Texas Roadhouse's Background
Texas Roadhouse Inc is a restaurant company operating predominately in the casual dining segment. The company's operating segment includes Texas Roadhouse; Bubba's 33 and others. It generates maximum revenue from the Texas Roadhouse segment.
Key Indicators: Texas Roadhouse's Financial Health
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: Texas Roadhouse displayed positive results in 3 months. As of 30 September, 2023, the company achieved a solid revenue growth rate of approximately 12.93%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Discretionary sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 5.69%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Texas Roadhouse's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 5.83%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 2.52%, the company showcases effective utilization of assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.69.
Understanding the Relevance of Analyst Ratings
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
